Allergy
- ANDERSSON LI, Kupczyk M, Dahlen B, Izuhara K, et al
Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex,
Weight, and Oral Steroid Treatment Than Disease Severity.
Allergy. 2026 Apr 3. doi: 10.1111/all.70318.
- ARASI S, Bitetti C, Lo Scalzo L, Spagnoli A, et al
Omalizumab Dose-Related Efficacy in a Cohort of Children With Severe Food
Allergy: OSAFA Observational Study.
Allergy. 2026 Jan 19. doi: 10.1111/all.70228.
- ALBERS GJ, Ogger PP, Michalaki C, Stolting H, et al
Protective Role for Itaconate During Inhaled Allergen Challenge.
Allergy. 2025 Oct 24. doi: 10.1111/all.70107.
- KORKMAZ RU, Omony J, Tan X, Klotz M, et al
The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic
Inflammation.
Allergy. 2026;81:1173-1192.
Ann Allergy Asthma Immunol
- MARQUES-MEJIAS A, Bartha I, Ciaccio CE, Chinthrajah RS, et al
Corrigendum to 'Skin as the target for allergy prevention and treatment' [Annals
of Allergy, Asthma & Immunology, Volume 133, Issue 2 (2024) 133-143].
Ann Allergy Asthma Immunol. 2026 Mar 28:S1081-1206(26)00116.
Chest
- KRISTIANSSON L, Seiler C, Braman Eriksson A, Sundh J, et al
Suggested novel risk factors for Swimming-Induced Pulmonary Edema - asthma and
limited open water swimming experience.
Chest. 2026 Mar 26:S0012-3692(26)00409-5. doi: 10.1016/j.chest.2026.
- DEPTA F, Sedlak V, Koblizek V, Bodnarova S, et al
Pulmonary Dynamics of the Bronchodilator Response in Volume-Responsive Asthma and
COPD.
Chest. 2026 Mar 26:S0012-3692(26)00418-6. doi: 10.1016/j.chest.2026.
Clin Exp Allergy
- MARRIOTT H, Adatia A, Moitra S, Lacy P, et al
Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in
Patients With Severe Asthma.
Clin Exp Allergy. 2026 Mar 27. doi: 10.1111/cea.70294.
Eur Respir J
- SHRAGER JB
Lung volume reduction surgery should be the default volume reduction approach for
most emphysema patients.
Eur Respir J. 2026;67:2502693.
- PERCH M, Corris P, Lordan J, Bessa V, et al
A European multi-center, randomized controlled trial of Pirfenidone in
bronchiolitis obliterans syndrome after bilateral lung transplantation.
Eur Respir J. 2025 Nov 13:2402154. doi: 10.1183/13993003.02154-2024.
- DIAB N, Brister D, Kum E, Wahab M, et al
Mepolizumab for the treatment of refractory chronic cough in patients with
eosinophilic airways disease (MUCOSA): a randomised, double-blind,
parallel-group, placebo-controlled trial.
Eur Respir J. 2026;67:2501573.
J Allergy Clin Immunol
- CHEN E, Jiang Y, Meng Z, Song Y, et al
Deep learning and statistical methods identify novel asthma risk variants in
Europeans.
J Allergy Clin Immunol. 2026 Apr 1:S0091-6749(26)00221.
J Asthma
- WU F
Nurse-Led Family Interactive Intervention in Children with Bronchial Asthma: A
Randomized Controlled Trial.
J Asthma. 2026 Apr 2:1-12. doi: 10.1080/02770903.2026.2654592.
- FERREIRO-POSSE AA, Mendoza-Zambrano E, Tiotiu A, Gonzalez-Barcala FJ, et al
The asthma-anxiety connection: friends or foes?
J Asthma. 2026 Apr 2:1-7. doi: 10.1080/02770903.2026.2654583.
J Investig Allergol Clin Immunol
- IZAGUIRRE-FLORES H, Arismendi E, Martin-Ruiz de la Rosa E, Roman-Bernal B, et al
Real-World Experience With Dupilumab in Severe Asthma: The Spanish Multicenter
Study DUPImpact.
J Investig Allergol Clin Immunol. 2026 Mar 30:0. doi: 10.18176/jiaci.1156.
JAMA
- ANDERER S
FDA Approves New Generic Inhaler for Asthma Treatment.
JAMA. 2026 Mar 27. doi: 10.1001/jama.2026.1024.
Pediatr Allergy Immunol
- AI Y, Zhu T, Gan J
Parental autoimmune diseases and offspring's allergic disease: A systematic
review and meta-analysis.
Pediatr Allergy Immunol. 2026;37:e70335.
Pediatr Pulmonol
- ZEREN M, Barlik M, Tosun BNC, Demir E, et al
Does Addition of Oscillatory Positive Expiratory Pressure (OPEP) Device to a
Chest Physiotherapy Program Provide Further Benefits in Children With
Bronchiectasis?: A Randomized Trial.
Pediatr Pulmonol. 2026;61:e71602.
- HOU J, Xiao J, Chen J, Wu S, et al
Bronchiolitis Obliterans as a Delayed Sequela of Mycoplasma pneumoniae
Complicated by Stevens-Johnson Syndrome in a Pediatric Patient.
Pediatr Pulmonol. 2026;61:e71610.
- LOVEYS K, Borland ML, Oakley E, Babl FE, et al
Investigations for Bronchiolitis in Infants: An Overview of Reviews and
Systematic Review of Primary Studies.
Pediatr Pulmonol. 2026;61:e71582.
Pediatr Rev
- JACOBSON MN, Jones BL
Single Maintenance and Reliever Therapy for the Pediatric Patients With Asthma.
Pediatr Rev. 2026;47:234-236.
PLoS Comput Biol
- ZHANG M, Kim YW, Yang CX, Gauvreau GM, et al
Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that
concurrently reverse disease signatures across multiple immune cell-types.
PLoS Comput Biol. 2026;22:e1014081.
PLoS One
- DRESPLING J, Heelemann S, Strathmeyer S, Kuhn H, et al
The transition from winter to spring has an impact on the airway metabolome
profile of asthmatic horses.
PLoS One. 2026;21:e0346250.
- CHEN Z, Ren X, Liu X, Tian L, et al
Deciphering the synergistic mechanism of a novel flavonoid-antioxidant
combination for asthma by combining systems pharmacology and experimental
validation.
PLoS One. 2026;21:e0346165.
- DE CASTRO MC, Moore DCBC, Camacho KG, Dos Santos Gomes SC Junior, et al
Factors associated with wheezing in Indigenous children and adolescents: A
systematic review of the global literature.
PLoS One. 2026;21:e0345711.
Pneumologie
- HOXHA E, Cocieru A
[A case of ABPA in a patient with asthma and bronchiectasis].
Pneumologie. 2026 Mar 30. doi: 10.1055/a-2819-4330.
Respir Med
- RODRIGUES J, Jesus B, Caseiro P, Rama L, et al
Body position and immersion associate with lung function differently in healthy
and asthmatic endurance athletes.
Respir Med. 2026;256:108783.
- SANTOS A, Silva L
Development and short-term effectiveness of a theory-informed, nurse-led
structured rehabilitation consultation in primary care asthma management.
Respir Med. 2026;256:108797.
- NAGASAKI T, Sato S, Murase K, Sunadome H, et al
COPD-sleep-disordered breathing overlap and vascular risk markers in non-obese
adults: The Nagahama study.
Respir Med. 2026;255:108777.
- ABULIZI A, Zhou J, Abudukelimu N, Yehaiya G, et al
A review of artificial intelligence-based research on chronic obstructive
pulmonary disease.
Respir Med. 2026;255:108778.
- WANG W, Zhang P, Xu T, Guo H, et al
Efficacy of high-flow nasal cannula versus conventional oxygen therapy in
high-risk patients undergoing bronchoscopy: a meta-analysis of RCTs.
Respir Med. 2026;255:108664.
Respir Res
- FISCHER BC, Drick N, Liu B, Riemann L, et al
B cell activating factor (BAFF) levels are associated with failed remission after
12 months of treatment with benralizumab and mepolizumab in severe asthma.
Respir Res. 2026 Apr 2. doi: 10.1186/s12931-026-03500.
- LV R, Li Z, Zhao C, Wang M, et al
B1 cells drive pulmonary emphysema progression through ADAM10.
Respir Res. 2026 Mar 31. doi: 10.1186/s12931-026-03640.
- KO FWS, Chan KKP, Ng TCC, Lo RLP, et al
A 3-year prospective study to assess clinical characteristics and risk factors
for exacerbations in patients with asthma-COPD overlap based on the GINA
guideline compared with patients with asthma and COPD.
Respir Res. 2026 Mar 29. doi: 10.1186/s12931-026-03643.
- MOON SW, Kim M, Kim EY, Kang C, et al
Longitudinal change of lung microbiome in chronic obstructive pulmonary disease:
a prospective cohort study.
Respir Res. 2026;27:152.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016